✦ LIBER ✦

Comparison of estrogen and progesterone receptor status to lymphocyte immunity against tumor antigens in breast cancer patients

✍ Scribed by Robert L. Elliott; Jonathan F. Head; James L. McCoy

Publisher: Springer US
Year: 1994
Tongue: English
Weight: 477 KB
Volume: 30
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf00665971

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic relevance of carcinoembryonic

Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients

✍ Jose M. Esteban; Barbara Felder; Chul Ahn; Jean F. Simpson; Hector Battifora; Jo 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 902 KB

Relationship of serum and tumor levels o

Relationship of serum and tumor levels of iron and iron-binding proteins to lymphocyte immunity against tumor antigen in breast cancer patients

✍ Robert L. Elliott; Jonathan F. Head; James L. McCoy 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 432 KB

Presence oferbB2mRNA in the plasma of br

Presence oferbB2mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status

✍ Ye Xu; Lihua Yao; Hongxia Li; Tao Ouyang; Jinfeng Li; Tianfeng Wang; Zhaoqing Fa 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 253 KB

Survival of premenopausal breast carcino

Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor

✍ Lucienne S. Cooper; Cheryl E. Gillett; Neera K. Patel; Diana M. Barnes; Ian S. F 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 3 views

## BACKGROUND. Premenopausal breast carcinoma patients who undergo tumor excision during the follicular phase of their menstrual cycle may have a significantly worse prognosis than those whose tumors are excised in other phases of the menstrual cycle. ## METHODS. Outcome was determined in a ser

Risk factors according to estrogen recep

Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India

✍ Subhojit Dey; Paolo Boffetta; Anitha Mathews; Paul Brennan; Amr Soliman; Aleyamm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 1 views

## Abstract Estrogen receptor (ER) status is an important biomarker in defining subtypes of breast cancer differing in antihormonal therapy response, risk factors and prognosis. However, little is known about association of ER status with various risk factors in the developing world. Our case–contr

Histochemical assay of estrogen and prog

Histochemical assay of estrogen and progesterone receptors in breast cancer: Correlation with biochemical assays and patients' response to endocrine therapies

✍ Louis P. Pertschuk; Ellis H. Tobin; Eric Gaetjens; Anne C. Carter; George A. Deg 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 697 KB

Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand-conjugates composed of 17P-estradiol and 1 lcu-hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescein isothiocyanate were emp